Eagle Boston Investment Management Inc buys $14,343,777 stake in PAREXEL International Corporation (PRXL)

PAREXEL International Corporation (PRXL) : Eagle Boston Investment Management Inc scooped up 5,747 additional shares in PAREXEL International Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 19, 2016. The investment management firm now holds a total of 219,828 shares of PAREXEL International Corporation which is valued at $14,343,777.PAREXEL International Corporation makes up approximately 1.87% of Eagle Boston Investment Management Inc’s portfolio.

Other Hedge Funds, Including , Nordea Investment Management Ab boosted its stake in PRXL in the latest quarter, The investment management firm added 7,795 additional shares and now holds a total of 10,475 shares of PAREXEL International Corporation which is valued at $683,494.Mai Capital Management reduced its stake in PRXL by selling 300 shares or 2.44% in the most recent quarter. The Hedge Fund company now holds 12,000 shares of PRXL which is valued at $774,120. PAREXEL International Corporation makes up approx 0.06% of Mai Capital Management’s portfolio.Trust Department Mb Financial Bank N A reduced its stake in PRXL by selling 76,699 shares or 90.1% in the most recent quarter. The Hedge Fund company now holds 8,427 shares of PRXL which is valued at $543,626. PAREXEL International Corporation makes up approx 0.06% of Trust Department Mb Financial Bank N A’s portfolio.Weaver C. Barksdale Associates boosted its stake in PRXL in the latest quarter, The investment management firm added 26 additional shares and now holds a total of 154 shares of PAREXEL International Corporation which is valued at $10,173. PAREXEL International Corporation makes up approx 0.02% of Weaver C. Barksdale Associates’s portfolio. Washington Trust Bank added PRXL to its portfolio by purchasing 46 company shares during the most recent quarter which is valued at $3,045.

PAREXEL International Corporation opened for trading at $64.5 and hit $65.71 on the upside on Wednesday, eventually ending the session at $65.25, with a gain of 1.83% or 1.17 points. The heightened volatility saw the trading volume jump to 2,59,953 shares. Company has a market cap of $3,451 M.

On the company’s financial health, PAREXEL International Corporation reported $0.89 EPS for the quarter, based on the information available during the earnings call on Apr 27, 2016. Analyst had a consensus estimate of $0.89. The company had revenue of $527.10 million for the quarter, compared to analysts expectations of $523.31 million. The company’s revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.66 EPS.

Many Wall Street Analysts have commented on PAREXEL International Corporation. Credit Suisse Initiated PAREXEL International Corporation on Jun 21, 2016 to “Outperform”, Price Target of the shares are set at $75.

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company which provides a range of expertise in clinical research clinical logistics medical communications consulting commercialization and advanced technology products and services to the pharmaceutical biotechnology and medical device industries across the world. The Company operates through three segments: Clinical Research Services PAREXEL Consulting Services and PAREXEL Informatics. Its product and service offerings include clinical trials management data management epidemiology health economics/outcomes research pharmacovigilance medical communications clinical pharmacology patient recruitment clinical supply and drug logistics post-marketing surveillance medical imaging services electronic data capture systems clinical trial management systems Web-based portals and other product development tools and services.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *